Trypanosoma avium incidence, pathogenicity and response to melarsomine in falcons from Kuwait
| Autor: | W Tarello |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2005 |
| Předmět: |
Male
medicine.medical_specialty Trypanosoma Veterinary (miscellaneous) medicine.medical_treatment Melarsomine Physiology Disease Biology chemotherapy Injections Intramuscular Arsenicals Host-Parasite Interactions lcsh:Infectious and parasitic diseases Lethargy bird of prey Trypanosoma avium Trypanosomiasis Epidemiology medicine Animals pathogenicity melarsomine lcsh:RC109-216 american_football Falconiformes Chemotherapy american_football.player Bird Diseases Triazines Incidence (epidemiology) Incidence Pathogenicity Trypanocidal Agents Infectious Diseases Treatment Outcome Kuwait Insect Science falcon Animal Science and Zoology Parasitology Female |
| Zdroj: | Parasite, Vol 12, Iss 1, Pp 85-87 (2005) |
| ISSN: | 1776-1042 |
| Popis: | Epidemiological and clinical studies on Trypanosoma avium are lacking in the Middle East. The aims of this study were to determine the T. avium incidence in falcons from Kuwait, report clinical signs and find an effective therapy. Blood smears from 921 diseased and 56 healthy falcons were examined between May 2003 and April 2004. 12 birds (1.3 %) were found infected by T. avium and ten of these were treated with melarsomine (Cymelarsan®) at a dosage of 0.25 mg/kg intramuscularly for four days. All affected birds presented clinical signs, including incapacity of flying high, poor appetite, lethargy, loosing weight, weakness, dyspnoea and death. Signs disappeared within 1-7 days after administration of melarsomine. Trypomastigotes were not detected in blood smears made 1-7 days after the end of therapy. This study suggests that T. avium induces disease in falcons and that melarsomine can be an effective therapy eliminating both clinical signs and circulating trypomastigotes. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|